Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease

被引:52
|
作者
El Tayara, NE
Delatour, B
Le Cudennec, C
Guégan, M
Volk, A
Dhenain, M [1 ]
机构
[1] Ctr Univ, INSERM, Inst Curie, Integrat Imaging Unit,Lab 112, F-91405 Orsay, France
[2] Univ Paris 11, UMR 8620, CNRS, Lab NAMC, F-91405 Orsay, France
关键词
Alzheimer's disease; amyloid; APP; biomarker; iron; MRI; PS1; T1; T2; transgenic mouse;
D O I
10.1016/j.nbd.2005.10.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T1 and T2 magnetic resonance relaxation times have the potential to provide biomarkers of amyloid-beta deposition that could be helpful to the development of new therapies for Alzheimer's disease. Here, we measured T1 and T2 times as well as plaques and iron loads in APP/PS1 mice, which model brain amyloidosis, and control PS1 mice. Iron was mostly associated with amyloid deposits in APP/PS1 animals, while it was diffuse in the PS1 mice. T1 was negatively correlated with age in most structures in APP/PS1 animals. This may be related to the age-associated myelin loss described in APP/PS1 mice rather than to amyloid deposition. T2 in the subiculum of adult APP/PS1 animals was lower than in PS1 mice, which may be related to the very high amyloid and iron loads in this region. T2 in the subiculum could thus serve as an early marker of the amyloid pathology. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 50 条
  • [31] Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a β-sheet breaker peptide
    Permanne, B
    Adessi, C
    Saborio, GP
    Fraga, S
    Frossard, MJ
    Van Dorpe, J
    Dewachter, I
    Banks, WA
    Van Leuven, F
    Soto, C
    FASEB JOURNAL, 2002, 16 (06): : 860 - +
  • [32] Age-Related Mitochondrial Alterations without Neuronal Loss in the Hippocampus of a Transgenic Model of Alzheimer's Disease
    Cuadrado-Tejedor, Mar
    Felipe Cabodevilla, Jesus
    Zamarbide, Marta
    Gomez-Isla, Teresa
    Franco, Rafael
    Perez-Mediavilla, Alberto
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (04) : 390 - 405
  • [33] Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease
    Halagappa, Veerendra Kumar Madald
    Guo, Zhihong
    Pearson, Michelle
    Matsuoka, Yasuji
    Cutler, Roy G.
    LaFerla, Frank M.
    Mattson, Mark P.
    NEUROBIOLOGY OF DISEASE, 2007, 26 (01) : 212 - 220
  • [34] Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease
    Kounnas, Maria Z.
    Danks, Anne M.
    Cheng, Soan
    Tyree, Curtis
    Ackerman, Elizabeth
    Zhang, Xulun
    Ahn, Kwangwook
    Nguyen, Phuong
    Comer, Dan
    Mao, Long
    Yu, Chengzhi
    Pleynet, David
    Digregorio, Paul J.
    Velicelebi, Gonul
    Stauderman, Kenneth A.
    Comer, William T.
    Mobley, William C.
    Li, Yue-Ming
    Sisodia, Sangram S.
    Tanzi, Rudolph E.
    Wagner, Steven L.
    NEURON, 2010, 67 (05) : 769 - 780
  • [35] Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease
    Rodrigo Morales
    Javiera Bravo-Alegria
    Claudia Duran-Aniotz
    Claudio Soto
    Scientific Reports, 5
  • [36] MR Microimaging of amyloid plaques in Alzheimer’s disease transgenic mice
    Thomas M. Wengenack
    Clifford R. Jack
    Michael Garwood
    Joseph F. Poduslo
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 82 - 88
  • [37] Genetic modifiers of amyloid-β production in a transgenic mouse model of Alzheimer's disease
    Ryman, DC
    Lamb, BT
    NEUROLOGY, 2006, 66 (05) : A379 - A379
  • [38] Peripheral neprilysin reduces brain amyloid in a transgenic mouse model of Alzheimer's disease
    Liu, Y. X.
    Guan, H. J.
    Klein, R.
    Oddo, S.
    LaFerla, F. M.
    Murphy, M. P.
    Hersh, L. B.
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 : 300 - 300
  • [39] Hypercholesterolemia accelerates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Refolo, L
    Duff, K
    Malester, B
    LaFrancois, J
    Wang, R
    Sambamurti, K
    Tint, GS
    Thomas, T
    Pappolla, MA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 424 - 424
  • [40] Mitochondrial dysfunction in amyloid precursor protein transgenic mouse model of Alzheimer's disease
    Scherping, I
    Czech, C
    Pradier, L
    Müller, WE
    Eckert, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R15 - R15